AI and biophysical modeling unite for novel protein design
An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...
Physicians Committee1d
New Comprehensive Review of Human Heart Models Demonstrates Their Utility in Understanding and Treating Cardiovascular Diseases
A review of human heart models—cardiac organoids and organ chips—showed that each method has unique advantages in different research contexts, including cardiac disease modeling and drug development.
JD Supra1d
A Model’s Credibility Is in the Details: FDA Draft Guidance on the Use of AI Models in Drug and Biological Product Development
In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...
FierceBiotech1d
Conduit taps Charles River to build preclinical autoimmune case for AstraZeneca diabetes asset
Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...
Chemistry World2d
Generative AI pipeline creates promising antimicrobial peptides
A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...
manilatimes2d
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study ...
labiotech2d
DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
ThePrint2d
Jubilant Biosys Limited Seals Deal with Pierre Fabre SA
Jubilant Biosys Innovative Research Services Pte. Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, has executed the ...
U.S. investors, Big Pharma race to find new medicines in China
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform
Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...
Hosted on MSN3d
'It will expand rapidly': How A.I. is changing drug development
One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...